Screener Summaries Updates Institutions Sign In More Updates › Leadership & Pay › TARS Leadership & Pay · Jul 13, 2026
Tarsus Pharmaceuticals, Inc. announced on July 13, 2026, that Chief Commercial Officer Aziz Mottiwala will depart from… TARS Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. announced on July 13, 2026, that Chief Commercial Officer Aziz Mottiwala will depart from the company on July 15, 2026, to become the CEO of a public medical device company. Tarsus Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing commercial-stage products for ocularly administered ocular diseases.
More from Tarsus Pharmaceuticals, Inc. Tarsus Reports Q3 Net Loss of $668.3M on $632.2M IPR&D Charge; XDEMVY Sales Rise 64% to $194.6M Nov 3, 2026 Tarsus Pharmaceuticals completes acquisition of Alkeus Pharmaceuticals Oct 13, 2026 On September 4, 2026, Tarsus Pharmaceuticals completed its acquisition of Alkeus Pharmaceuticals Sep 10, 2026 Tarsus Pharmaceuticals reported second-quarter 2026 net product sales of $173.9 million, a 69% year-over-year… Aug 6, 2026 Tarsus Pharmaceuticals, Inc. entered into a Securities Purchase Agreement on August 5, 2026, for an oversubscribed… Aug 6, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
